The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial

The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial

Background: Alcoholic hepatitis (AH) is a distinct presentation of alcoholic liver disease arising in patients who have been drinking to excess for prolonged periods, which is characterised by jaundice and liver failure. Severe disease is associated with high short-term mortality. Prednisolone and p...

Full description

Bibliographic Details
Main Authors: Mark Thursz, Ewan Forrest, Paul Roderick, Christopher Day, Andrew Austin, John O’Grady, Stephen Ryder, Michael Allison, Dermot Gleeson, Anne McCune, David Patch, Mark Wright, Steven Masson, Paul Richardson, Luke Vale, Jane Mellor, Louise Stanton, Megan Bowers, Ian Ratcliffe, Nichola Downs, Scott Kirkman, Tara Homer, Laura Ternent
Format: Article
Language:English
Published: NIHR Journals Library 2015-12-01
Series:Health Technology Assessment
Subjects:
randomised controlled trial
double-blind
2 x 2 factorial
pentoxifylline
steroids
prednisolone
alcoholic hepatitis
Online Access:https://doi.org/10.3310/hta191020

Internet

https://doi.org/10.3310/hta191020

Similar Items